Everyone likes uranium when the chart is moving.
But if the sector went sideways for 12 months, which name would you still be comfortable holding?
Everyone likes uranium when the chart is moving.
But if the sector went sideways for 12 months, which name would you still be comfortable holding?
Everyone likes uranium when the chart is moving.
But if the sector went sideways for 12 months, which name would you still be comfortable holding?
Everyone likes uranium when the chart is moving.
But if the sector went sideways for 12 months, which name would you still be comfortable holding?
I’ve been looking at $FPC after the recent CEO interview, and Horne 5 is one of those projects where the numbers look strong, but the path to development still needs to be watched closely.
From the interview and latest FS:
For me, the main debate is straightforward: the economics look strong, and the next step is seeing how $FPC moves through permitting and financing toward development.
For people who follow mining developers, what matters more at this stage: strong project economics, or a clear plan to fund construction?
Paid Content, DYOD.
I’ve been looking at $FPC after the recent CEO interview, and Horne 5 is one of those projects where the numbers look strong, but the path to development still needs to be watched closely.
From the interview and latest FS:
For me, the main debate is straightforward: the economics look strong, and the next step is seeing how $FPC moves through permitting and financing toward development.
For people who follow mining developers, what matters more at this stage: strong project economics, or a clear plan to fund construction?
Paid Content, DYOD.
I’ve been looking at $FPC after the recent CEO interview, and Horne 5 is one of those projects where the numbers look strong, but the path to development still needs to be watched closely.
From the interview and latest FS:
For me, the main debate is straightforward: the economics look strong, and the next step is seeing how $FPC moves through permitting and financing toward development.
For people who follow mining developers, what matters more at this stage: strong project economics, or a clear plan to fund construction?
Paid Content, DYOD
I’ve been looking at $FPC after the recent CEO interview, and Horne 5 is one of those projects where the numbers look strong, but the path to development still needs to be watched closely.
From the interview and latest FS:
For me, the main debate is straightforward: the economics look strong, and the next step is seeing how $FPC moves through permitting and financing toward development.
For people who follow mining developers, what matters more at this stage: strong project economics, or a clear plan to fund construction?
Paid Content, DYOD.
If you follow the consumer growth space, you know the modern oral pouch market is absolutely on fire. Zyn turned the nicotine world upside down, and now a massive structural shift is moving into caffeine, nootropics, and functional energy.
What caught my attention recently was the FDA news.
According to recent reports, the FDA is taking a more permissive approach toward new vapes and nicotine pouches, potentially allowing hundreds of additional products onto the market. While Doseology's products are nicotine-free, the news highlights growing regulatory support and consumer familiarity with pouch-based formats.
That made me take a closer look at Doseology Sciences ($MOOD / $DOSEF).
The company recently launched its Feed That Brain® oral stimulant pouches in the U.S. through Amazon and direct-to-consumer channels. Earlier this year, it also announced a $2 million financing to accelerate commercialization, manufacturing, inventory, marketing, and distribution. More recently, it uplisted to the OTCQB under the ticker DOSEF, expanding access for U.S. investors.
When you put those developments together, the timing stands out. Consumer awareness of pouch products is growing, the company is investing to scale its platform, and U.S. investors now have easier access to the story.
The obvious comparison is nicotine pouches. A few years ago, very few investors were paying attention to that category. Today, it's one of the fastest-growing segments in the industry, with major tobacco companies investing heavily in it.
Doseology is still early-stage, so execution remains the biggest factor to watch. But it appears to be positioning itself in an emerging category just as several industry tailwinds are beginning to align.
Open to hearing different viewpoints here. Are investors overlooking oral stimulant pouches, or is awareness starting to build?
This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.
If you follow the consumer growth space, you know the modern oral pouch market is absolutely on fire. Zyn turned the nicotine world upside down, and now a massive structural shift is moving into caffeine, nootropics, and functional energy.
What caught my attention recently was the FDA news.
According to recent reports, the FDA is taking a more permissive approach toward new vapes and nicotine pouches, potentially allowing hundreds of additional products onto the market. While Doseology's products are nicotine-free, the news highlights growing regulatory support and consumer familiarity with pouch-based formats.
That made me take a closer look at Doseology Sciences ($MOOD / $DOSEF).
The company recently launched its Feed That Brain® oral stimulant pouches in the U.S. through Amazon and direct-to-consumer channels. Earlier this year, it also announced a $2 million financing to accelerate commercialization, manufacturing, inventory, marketing, and distribution. More recently, it uplisted to the OTCQB under the ticker DOSEF, expanding access for U.S. investors.
When you put those developments together, the timing stands out. Consumer awareness of pouch products is growing, the company is investing to scale its platform, and U.S. investors now have easier access to the story.
The obvious comparison is nicotine pouches. A few years ago, very few investors were paying attention to that category. Today, it's one of the fastest-growing segments in the industry, with major tobacco companies investing heavily in it.
Doseology is still early-stage, so execution remains the biggest factor to watch. But it appears to be positioning itself in an emerging category just as several industry tailwinds are beginning to align.
Open to hearing different viewpoints here. Are investors overlooking oral stimulant pouches, or is awareness starting to build?
This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.
If you follow the consumer growth space, you know the modern oral pouch market is absolutely on fire. Zyn turned the nicotine world upside down, and now a massive structural shift is moving into caffeine, nootropics, and functional energy.
What caught my attention recently was the FDA news.
According to recent reports, the FDA is taking a more permissive approach toward new vapes and nicotine pouches, potentially allowing hundreds of additional products onto the market. While Doseology's products are nicotine-free, the news highlights growing regulatory support and consumer familiarity with pouch-based formats.
That made me take a closer look at Doseology Sciences ($MOOD / $DOSEF).
The company recently launched its Feed That Brain® oral stimulant pouches in the U.S. through Amazon and direct-to-consumer channels. Earlier this year, it also announced a $2 million financing to accelerate commercialization, manufacturing, inventory, marketing, and distribution. More recently, it uplisted to the OTCQB under the ticker DOSEF, expanding access for U.S. investors.
When you put those developments together, the timing stands out. Consumer awareness of pouch products is growing, the company is investing to scale its platform, and U.S. investors now have easier access to the story.
The obvious comparison is nicotine pouches. A few years ago, very few investors were paying attention to that category. Today, it's one of the fastest-growing segments in the industry, with major tobacco companies investing heavily in it.
Doseology is still early-stage, so execution remains the biggest factor to watch. But it appears to be positioning itself in an emerging category just as several industry tailwinds are beginning to align.
Open to hearing different viewpoints here. Are investors overlooking oral stimulant pouches, or is awareness starting to build?
This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.
If you follow the consumer growth space, you know the modern oral pouch market is absolutely on fire. Zyn turned the nicotine world upside down, and now a massive structural shift is moving into caffeine, nootropics, and functional energy.
What caught my attention recently was the FDA news.
According to recent reports, the FDA is taking a more permissive approach toward new vapes and nicotine pouches, potentially allowing hundreds of additional products onto the market. While Doseology's products are nicotine-free, the news highlights growing regulatory support and consumer familiarity with pouch-based formats.
That made me take a closer look at Doseology Sciences ($MOOD / $DOSEF).
The company recently launched its Feed That Brain® oral stimulant pouches in the U.S. through Amazon and direct-to-consumer channels. Earlier this year, it also announced a $2 million financing to accelerate commercialization, manufacturing, inventory, marketing, and distribution. More recently, it uplisted to the OTCQB under the ticker DOSEF, expanding access for U.S. investors.
When you put those developments together, the timing stands out. Consumer awareness of pouch products is growing, the company is investing to scale its platform, and U.S. investors now have easier access to the story.
The obvious comparison is nicotine pouches. A few years ago, very few investors were paying attention to that category. Today, it's one of the fastest-growing segments in the industry, with major tobacco companies investing heavily in it.
Doseology is still early-stage, so execution remains the biggest factor to watch. But it appears to be positioning itself in an emerging category just as several industry tailwinds are beginning to align.
Open to hearing different viewpoints here. Are investors overlooking oral stimulant pouches, or is awareness starting to build?
This is sponsored content. Investors should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.
Cybersecurity still gets framed around U.S. giants, but Europe has a few public names to watch as defense budgets, data privacy, and digital sovereignty move higher on the priority list.
$YSN.DE — secunet Security Networks
German cyber name with deep public-sector exposure.
Price: ~€160s–€180s | Market cap: ~€1.1B–€1.3B
$FSECURE.HE — F-Secure
Finnish identity protection and endpoint security company.
Price: ~€2.00 | Market cap: ~€350M
$WIIT.MI — WIIT
Italian secure cloud and disaster recovery operator.
Price: ~€33–€34 | Market cap: ~€820M–€890M
$NCC.L — NCC Group
UK cyber assurance and consulting business.
Price: ~122p | Market cap: ~£340M–£350M
$SKUR.CN / $SWISF — Sekur Private Data
Swiss-hosted private communications platform with micro-cap exposure.
Price: ~C$0.05–C$0.06 | Market cap: ~C$12M–C$14M
Yesterday update on $SKUR: SekurOne is now available on Android and Web, and the company says it completed its first encrypted domestic and international calls across devices.
The larger names give this theme more credibility, while $SKUR adds the early-stage micro-cap angle if secure communications and privacy demand keeps building. I like this group because it connects national security, cloud protection, data sovereignty, and government demand in one sector.
Anyone here following any names on this list?
Paid content. Not financial advice.
Cybersecurity still gets framed around U.S. giants, but Europe has a few public names to watch as defense budgets, data privacy, and digital sovereignty move higher on the priority list.
$YSN.DE — secunet Security Networks
German cyber name with deep public-sector exposure.
Price: ~€160s–€180s | Market cap: ~€1.1B–€1.3B
$FSECURE.HE — F-Secure
Finnish identity protection and endpoint security company.
Price: ~€2.00 | Market cap: ~€350M
$WIIT.MI — WIIT
Italian secure cloud and disaster recovery operator.
Price: ~€33–€34 | Market cap: ~€820M–€890M
$NCC.L — NCC Group
UK cyber assurance and consulting business.
Price: ~122p | Market cap: ~£340M–£350M
$SKUR.CN / $SWISF — Sekur Private Data
Swiss-hosted private communications platform with micro-cap exposure.
Price: ~C$0.05–C$0.06 | Market cap: ~C$12M–C$14M
Yesterday update on $SKUR: SekurOne is now available on Android and Web, and the company says it completed its first encrypted domestic and international calls across devices.
The larger names give this theme more credibility, while $SKUR adds the early-stage micro-cap angle if secure communications and privacy demand keeps building. I like this group because it connects national security, cloud protection, data sovereignty, and government demand in one sector.
Anyone here following any names on this list?
Paid content. Not financial advice.
Cybersecurity still gets framed around U.S. giants, but Europe has a few public names to watch as defense budgets, data privacy, and digital sovereignty move higher on the priority list.
$YSN.DE — secunet Security Networks
German cyber name with deep public-sector exposure.
Price: ~€160s–€180s | Market cap: ~€1.1B–€1.3B
$FSECURE.HE — F-Secure
Finnish identity protection and endpoint security company.
Price: ~€2.00 | Market cap: ~€350M
$WIIT.MI — WIIT
Italian secure cloud and disaster recovery operator.
Price: ~€33–€34 | Market cap: ~€820M–€890M
$NCC.L — NCC Group
UK cyber assurance and consulting business.
Price: ~122p | Market cap: ~£340M–£350M
$SKUR.CN / $SWISF — Sekur Private Data
Swiss-hosted private communications platform with micro-cap exposure.
Price: ~C$0.05–C$0.06 | Market cap: ~C$12M–C$14M
Yesterday update on $SKUR: SekurOne is now available on Android and Web, and the company says it completed its first encrypted domestic and international calls across devices.
The larger names give this theme more credibility, while $SKUR adds the early-stage micro-cap angle if secure communications and privacy demand keeps building. I like this group because it connects national security, cloud protection, data sovereignty, and government demand in one sector.
Anyone here following any names on this list?
Paid content. Not financial advice.
Cybersecurity still gets framed around U.S. giants, but Europe has a few public names to watch as defense budgets, data privacy, and digital sovereignty move higher on the priority list.
$YSN.DE — secunet Security Networks
German cyber name with deep public-sector exposure.
Price: ~€160s–€180s | Market cap: ~€1.1B–€1.3B
$FSECURE.HE — F-Secure
Finnish identity protection and endpoint security company.
Price: ~€2.00 | Market cap: ~€350M
$WIIT.MI — WIIT
Italian secure cloud and disaster recovery operator.
Price: ~€33–€34 | Market cap: ~€820M–€890M
$NCC.L — NCC Group
UK cyber assurance and consulting business.
Price: ~122p | Market cap: ~£340M–£350M
$SKUR.CN / $SWISF — Sekur Private Data
Swiss-hosted private communications platform with micro-cap exposure.
Price: ~C$0.05–C$0.06 | Market cap: ~C$12M–C$14M
Yesterday update on $SKUR: SekurOne is now available on Android and Web, and the company says it completed its first encrypted domestic and international calls across devices.
The larger names give this theme more credibility, while $SKUR adds the early-stage micro-cap angle if secure communications and privacy demand keeps building. I like this group because it connects national security, cloud protection, data sovereignty, and government demand in one sector.
Anyone here following any names on this list?
Paid content. Not financial advice.
Most AI talk goes straight to chips, data centers and power demand. But the physical side of AI needs a lot of copper too.
More data centers means more grid buildout, more transmission, more wiring and more pressure on copper supply.
That is why I’m looking more closely at Canadian small-cap and micro-cap copper names with real exploration work ahead, not just old land packages.
A few on my watchlist:
$CQX: around C$0.13 to C$0.16, approx. C$14M to C$16M market cap. Copper-gold exposure through Kitimat, Rip and Stars, with AI-assisted targeting at Kitimat and 2026 exploration activity across the portfolio.
$TMET.V: around C$0.13, approx. C$11M market cap. BC copper-gold explorer around the Kolos project in the Quesnel Terrane.
$KDK.V: around C$0.90 to C$0.95, approx. C$85M to C$95M market cap. BC copper-gold porphyry explorer with the MPD project and a funded 2026 exploration program.
$SURG.V: larger than the others, around C$0.55 to C$0.80, approx. C$190M to C$300M market cap. Worth comparing as a BC copper developer advancing the Berg project.
The macro theme is clear, but juniors still need their own catalyst: drilling, assays, target updates, financing, or a partner.
Which Canadian small-cap copper or copper-gold junior do you think is best placed if the AI/grid copper narrative keeps growing?
Paid content. Not financial advice.
Most AI talk goes straight to chips, data centers and power demand. But the physical side of AI needs a lot of copper too.
More data centers means more grid buildout, more transmission, more wiring and more pressure on copper supply.
That is why I’m looking more closely at Canadian small-cap and micro-cap copper names with real exploration work ahead, not just old land packages.
A few on my watchlist:
$CQX: around C$0.13 to C$0.16, approx. C$14M to C$16M market cap. Copper-gold exposure through Kitimat, Rip and Stars, with AI-assisted targeting at Kitimat and 2026 exploration activity across the portfolio.
$TMET.V: around C$0.13, approx. C$11M market cap. BC copper-gold explorer around the Kolos project in the Quesnel Terrane.
$KDK.V: around C$0.90 to C$0.95, approx. C$85M to C$95M market cap. BC copper-gold porphyry explorer with the MPD project and a funded 2026 exploration program.
$SURG.V: larger than the others, around C$0.55 to C$0.80, approx. C$190M to C$300M market cap. Worth comparing as a BC copper developer advancing the Berg project.
The macro theme is clear, but juniors still need their own catalyst: drilling, assays, target updates, financing, or a partner.
Which Canadian small-cap copper or copper-gold junior do you think is best placed if the AI/grid copper narrative keeps growing?
Paid content. Not financial advice.
Most AI talk goes straight to chips, data centers and power demand. But the physical side of AI needs a lot of copper too.
More data centers means more grid buildout, more transmission, more wiring and more pressure on copper supply.
That is why I’m looking more closely at Canadian small-cap and micro-cap copper names with real exploration work ahead, not just old land packages.
A few on my watchlist:
$CQX: around C$0.13 to C$0.16, approx. C$14M to C$16M market cap. Copper-gold exposure through Kitimat, Rip and Stars, with AI-assisted targeting at Kitimat and 2026 exploration activity across the portfolio.
$TMET.V: around C$0.13, approx. C$11M market cap. BC copper-gold explorer around the Kolos project in the Quesnel Terrane.
$KDK.V: around C$0.90 to C$0.95, approx. C$85M to C$95M market cap. BC copper-gold porphyry explorer with the MPD project and a funded 2026 exploration program.
$SURG.V: larger than the others, around C$0.55 to C$0.80, approx. C$190M to C$300M market cap. Worth comparing as a BC copper developer advancing the Berg project.
The macro theme is clear, but juniors still need their own catalyst: drilling, assays, target updates, financing, or a partner.
Which Canadian small-cap copper or copper-gold junior do you think is best placed if the AI/grid copper narrative keeps growing?
Paid content. Not financial advice.
Most AI talk goes straight to chips, data centers and power demand. But the physical side of AI needs a lot of copper too.
More data centers means more grid buildout, more transmission, more wiring and more pressure on copper supply.
That is why I’m looking more closely at Canadian small-cap and micro-cap copper names with real exploration work ahead, not just old land packages.
A few on my watchlist:
$CQX: around C$0.13 to C$0.16, approx. C$14M to C$16M market cap. Copper-gold exposure through Kitimat, Rip and Stars, with AI-assisted targeting at Kitimat and 2026 exploration activity across the portfolio.
$TMET.V: around C$0.13, approx. C$11M market cap. BC copper-gold explorer around the Kolos project in the Quesnel Terrane.
$KDK.V: around C$0.90 to C$0.95, approx. C$85M to C$95M market cap. BC copper-gold porphyry explorer with the MPD project and a funded 2026 exploration program.
$SURG.V: larger than the others, around C$0.55 to C$0.80, approx. C$190M to C$300M market cap. Worth comparing as a BC copper developer advancing the Berg project.
The macro theme is clear, but juniors still need their own catalyst: drilling, assays, target updates, financing, or a partner.
Which Canadian small-cap copper or copper-gold junior do you think is best placed if the AI/grid copper narrative keeps growing?
Paid content. Not financial advice.